STAAR Surgical rises premarket after Q3 prelim sales beat
20/10/2025 14:09
** Shares of implantable eye lens maker STAAR Surgical STAA.O rise 3.17% to $25.03 premarket ** Co reports preliminary Q3 sales of $94.7 mln, above analysts' estimate of $93.3 mln, according to data compiled by LSEG ** Q3 sales growth boosted by a $25.9 mln deferred China shipment and 7.7% growth in net sales outside China ** YTD, the stock has risen 3.05% (Reporting by Krisha Bhatt) ((Krisha.Bhatt@thomsonreuters.com;))